Skip to content

Biogen BIIB Common Stock

Common Stock at other companies

Eli Lilly logo
Eli LillyLLY
$590M-0.4%
Rogers Corporation logo
Rogers CorporationROG
$17.9M-1.1%
TG Therapeutics logo
TG TherapeuticsTGTX
$160K+0.6%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$16K0.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$29K-3.3%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$9K0.0%

Other financials

Income statement

See full
Revenue$2.7B+3.4%
Gross profit$2.0B-4.0%
Operating income$610.7M
Net income$97.5M-84.6%
EPS (diluted)$0.66-84.8%

Balance sheet

See full
Cash & equivalents$1.3B-53.4%
Total debt$7.6B+14.6%
Total equity$18.8B+6.9%
Total assets$32.1B+13.3%

Cash flow

See full
Operating cash flow$448.9M+179%
CapEx$40.9M+53.8%
Free cash flow$408.0M+204%

Valuation

See full
Market cap$30.36B+66.6%
Enterprise value$36.63B+66.1%
P/E34.4×+22.5×
P/S+1.2×

Profitability

See full
Gross margin74%-1.4pp
Operating margin22.9%
Net margin8.8%-6.5pp
FCF margin26.9%+7.1pp

Returns & leverage

See full
Return on equity4.8%-4.3pp
Debt / equity0.4×0.0×
Current ratio1.9×-0.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Biogen’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's common stock?
Biogen (BIIB) reported common stock of $100K in Q2 2026.
How has Biogen's common stock changed year-over-year?
Biogen's common stock decreased by 0.0% year-over-year, from $100K to $100K.
What is the long-term trend for Biogen's common stock?
Over 5 years (2020 to 2025), Biogen's common stock has grown at a -84.2% compound annual growth rate (CAGR), from $1B to $100K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).